ENTITY
JD Health International

JD Health International (6618 HK)

433
Analysis
Consumer Staples • China
JD Health International Inc. operates drug stores. The Company retails Chinese and Western medicines, nutrition products, health care products, and other products. JD Health International markets its products throughout China.
more
•13 Nov 2020 14:26

JD Health (京东偄康) Pre-IPO - Assumptions and Valuations

JD Health was said to be approved by HKEX for IPO. We look at our assumptions and forecast as well as compare valuation to listed peers.

Share
•10 Nov 2020 09:41

China Healthcare Weekly (Nov.6)

This article summarized the new healthcare policy released in China, major industry viewpoints, company news and capital markets review for the...

Logo
367 Views
Share
•10 Nov 2020 00:41

JD Health IPO Initiation: E-Ppointments

JD Health’s IPO is well-timed to benefit from the strong investor sentiment on online healthcare platforms. Overall, JD Health’s fundamentals...

Logo
450 Views
Share
•09 Nov 2020 08:58

JD Health (京东偄康) Pre-IPO - Peer Comparison - It's a Close Fight and Competition Is Intensifying

JD Health (JDH HK) is looking to raise about US$3bn in its upcoming Hong Kong IPO. We are hearing that the company is seeking listing approval....

Share
bullish•Ant Group
•08 Nov 2020 10:26

ECM Weekly (8 November 2020) - Ant, Sunac Svcs, Jinke Svcs, Antengene, Gland Pharma, Kalyan Jewel

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
x